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Objectives. Conventional bedside tests of visuospatial function such as the clock drawing (CDT) and intersecting
pentagons tests (IPT) are subject to considerable inconsistency in their delivery and interpretation. We compared perfor-
mance on a novel test – the letter and shape drawing (LSD) test –with these conventional tests in hospitalised elderly patients.
Methods. The LSD, IPT, CDT and the Montreal Cognitive Assessment (MoCA) were performed in 40 acute elderly
medical inpatients at University Hospital Limerick The correlation between these tests was examined as well as the
accuracy of the visuospatial tests to identify significant cognitive impairment on the MoCA.
Results. The patients (mean age 81.0± 7.71; 21 female) had a median MoCA score of 15.5 (range = 1–29). There was a
strong, positive correlation between the LSD and both the CDT (r = 0.56) and IPT (r = 0.71). The correlation between the
LSD and MoCA (r = 0.91) was greater than for the CDT and IPT (both 0.67). The LSD correlated highly with all MoCA
domains (ranging from 0.54 to 0.86) and especially for the domains of orientation (r = 0.86), attention (0.81) and
visuospatial function (r = 0.73). Two or more errors on the LSD identified 90% (26/29) of those patients with MoCA
scores of ⩽ 20, which was substantially higher than for the CDT (59%) and IPT (55%).
Conclusion. The LSD is a novel test of visuospatial function that is brief, readily administered and easily interpreted.
Performance correlates strongly with other tests of visuospatial ability, with favourable ability to identify patients with
significant impairment of general cognition.
Received 17 December 2015; Revised 25 March 2016; Accepted 12 August 2016; First published online 2 November 2016
Key words: Assessment, cognition, letter and shape drawing test, Montreal Cognitive Assessment tool, visuospatial.
Introduction
Visuospatial constructive cognition is the ability to
observe and reproduce a visual image, including its
components. Traditionally, this ability is tested through
tests of drawing and functional tasks such as buttoning
shirts, constructing models, making a bed and assem-
bling objects such as furniture (Giannakopoulos et al.
1998). Visuospatial function is commonly impaired in
major neurocognitive disorders (Meagher et al. 2007,
2010; Brown et al. 2009) and is tested in the two most
popular bedside instruments for assessment of cogni-
tive function – the Montreal Cognitive Assessment
(MoCA) (Nasreddine et al. 2005) which includes the
clock drawing test (CDT), and Mini Mental State
Examination (MMSE) (Folstein et al. 1975) which
includes the intersecting pentagon test (IPT). These tests
are relatively easy to administer, sensitive to
cognitive changes with good predictive validity for
significant cognitive disorder, and correlate sig-
nificantly with other standardised screening tests of
cognition such as the Cambridge Cognition Examina-
tion and the MMSE (Bourke et al. 1995; Shulman, 2000).
However, the CDT has multiple versions with
different scoring methods such that there is a lack of
consistency in testing and interpretation. Moreover, its
validity is impacted upon by issues such as language,
culture and level of education of the subject being
assessed (Pinto & Peters, 2009). Price et al. (2011) found
that both inter and intra-rater reliability of the CDT
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were low without repeated training. Similarly, the IPT
is also complicated by inconsistency in scoringmethods
(Helmes, 2013).
The letter and shape drawing (LSD) test is a novel
test developed by the Cognitive Impairment Research
Group (CIRG) at the University of Limerick Medical
School. It aims to provide a test of visuospatial ability
that is simpler than existing bedside tests (e.g. clock
drawing) and that can be readily presented via
computer-assisted devices to allow for convenient and
reliable testing. Moreover, it is also expected that it
would be brief; easy to administer; acceptable to older
persons; minimally affected by education, sex and
age, with high sensitivity and specificity for major
neurocognitive disorders (Borson et al. 2003).
The objective of this pilot study was to investigate
how the LSD test performs in comparison with
conventional tests of visuospatial function (specifically
the CDT and IPT) as well as generalised cognition
(as measured on the MoCA) in medically unwell
hospital inpatients over the age of 65.
Methods
This was a cross-sectional study carried out at
University Hospital Limerick, Ireland between
December 2013 and February 2014.
The subjects of the study comprised hospitalised
elderly medical patients aged 65 years and above who
were receiving care in the general wards of University
Hospital Limerick (Ireland). The patients were
consecutively referred by the medical team as deemed
well enough to participate. They were specifically
assessed for dementia (evident from clinical case-notes
or collateral history) and all participants were assessed
for possible delirium assessed using the confusion
assessment method (CAM) (Inouye et al. 1990).
Measures
All participants were assessed with the following series
of tests; the CAM, MoCA, IPT, CDT and the LSD. All
tests were administered in a single session by the same
assessor and in the order listed. The LSD test was pre-
sented last in order to minimise any possible advantage
due to less fatigue that might be conferred by being
presented earlier in the series of tests.
CAM
The presence of possible delirium was assessed using
the CAM (Inouye et al. 1990). The CAM is the most
widely used screening tool for delirium (Wei et al. 2008).
All CAM assessments were performed by a researcher
(D.W.) who was formally trained in its use.
MoCA
The MoCA is a screening tool for the detection of
general cognitive impairment (Nasreddine et al. 2005).
It assesses attention and concentration, executive
function, memory, language, visuo-constructional
skills, conceptual thinking, calculation and orienta-
tion. Visuospatial ability is assessed using a clock-
drawing task (three points) and a three-dimensional
cube copy (one point). The total possible score is
30 points; a score of ⩾26 is considered normal but other
work has suggested a cut-off score of 20 or less points
as indicative of significant cognitive impairment
(Waldron-Perrine & Axelrod, 2012). The MoCA was
administered in keeping with the Montreal Cognitive
Assessment Administration and Scoring Instructions
(available at www.mocatest.org). The sensitivity and
specificity of the MoCA for significant cognitive
impairment are high (both >85%), it has high inter-rater
and test–retest reliability and, in contrast to the
MMSE, is less prone to ceiling effects as performance
is normally distributed (Nasreddine et al. 2005;
Koski, 2013).
IPT
This is a geometric copying test derived from the
original Bender Gestalt test (1938). The subject is
presented with a copy of two intersecting pentagons
drawn at angles to one another producing a diamond
shape where they overlap. The subject is then requested
to copy the design on the blank half of the page. For
scoring, we applied the six-point hierarchical scoring
scale developed by Bourke et al. (1995), where 6 repre-
sents a perfect reproduction and 1 represents the
poorest effort (see Table 1). A score of <4 is considered
to reflect a failed performance. This scale allows for
sensitive and objective assessment of the range of
possible performances.
CDT
The CDT examines visuospatial abilities as well as
receptive language, numerical knowledge, working
memory and executive functions (both motor and
cognitive) (Freedman et al. 1994). It is widely used in
geriatric practice, where it can provide a brief ‘cognitive
scan’ (Lezak et al. 2004). In this study, subjects were
provided with a pre-drawn circle onto which the
participant was requested to place all the numbers and
the large and small hands on the clock face to show the
time ‘ten past eleven’. We used the scoring method of
Sunderland et al. (1989) which ranges from 0 to 10
according to spatial representation of the numbers
and hands of the clock (see Table 1). A score of <6 is
considered a failed performance.
170 D. White et al.
LSD test
The LSD test is a novel instrument developed by
the Cognitive Impairment Research Group at the
University of Limerick. It is designed to emphasise
visuospatial abilities over other functions that are rele-
vant to performance on tests of constructional abilities
(e.g. fine motor skills). The initial design was piloted
for acceptability and coverage in a series of trials in a
nursing home population with varying degrees of
cognitive impairment. The test includes a series of 15
designs that link 1 cm spheres arranged in increasingly
complex 3× 3, 4 × 4, 5 × 5 and 6× 6 grids that the subject
copies to an adjacent blank grid (e.g. see Fig. 1).
Each grid occupies one half of an A5 page. A correct
performance requires that all relevant spheres are
connected to complete the required shape. Omissions
(but not commissions) are rated as errors. As such,
performance can be precisely determined as a correct
reproduction of the letter or shape or not. Subjects are
permitted a single trial of each of the 15 items. The
test typically takes 5 minutes to complete. The current
version is presented in a pen and paper format but is
designed to allow for ease of transfer to a touch sensi-
tive grid on an android tablet platform. Performance
was measured by totalling the number of correctly
completed grids (scoring range 0–15).
Data collection
Scoring of the CDT, IPT and LSDwas achieved through
a consensus group comprised of members of the CIRG
(D.W., O.W., M.L., D.M.). The typical completion times
for the full test battery were 30 minutes.
Ethical approval
The procedures and rationale for the assessments were
explained to all participants but because many
patients had possible delirium and/or dementia at
entry into these studies it was presumed that some
would not be capable of giving informed written
consent. The University Hospital Limerick Research
Ethics Committee approved an approach whereby
patient verbal assent was augmented with proxy
consent from next of kin (where possible) or a
responsible caregiver. This is in accordance with the
Helsinki Guidelines for Medical research involving
Table 1. Scoring systems for the interlocking pentagon test (IPT)




5 Two figures intersecting with one pentagon or
additional lines joining pentagons together
4 Two figures drawn and intersecting
3 Two figures not intersecting (but can be adjoining)
2 One closed figure drawn
1 Lines drawn not making a closed figure, or no attempt
CDT
10 Hands and numbers are all present and in the correct
positions. Corrections without prompting are
accepted as normal
9 There are slight errors in placement of hands or one
missing number without spacing errors
8 There are moderate errors in placement of hands,
confusion as to small and large hands or spacing
errors alone
7 The placement of hands is significantly off course or
spacing is inappropriate
6 Clock hands are used inappropriately or there is use of
digital display, circling of numbers or perseveration
in the writing of numbers
5 Numbers are crowded to one end of the clock, reversed
in order or absent
4 There is further distortion of the number sequence,
counter-clockwise order, many missing numbers, or
numbers placed outside of the clock face border
3 The numbers and clock face are no longer connected in
the drawing
2 Only vague representation of a clock or irrelevant
spatial representation exist
1 The result is not interpretable or no attempt is made
Fig. 1. Sample items from the letter and shape drawing test.
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human subjects (World Medical Association, 2004).
These assessment procedures did not have any identi-
fied significant risks but the patient and family/carers
were informed that they could withdraw participation
at any stage
Statistical analysis
Statistical analysis was conducted using the statis-
tical software package SPSS for Windows Version
19. Continuous variables were tested for normality
and reported as means (standard deviation) or
median (range), while categorical variables are
reported as counts and percentages. Spearman’s
correlation coefficient was used to measure the
strength of association between total LSD score and
the CDT, IPT, MoCA and individual neuropsycho-
logical domains of the MoCA. The optimal cut-off
score for the LSD for identifying impaired perfor-
mance on the MoCA (score ⩽ 20) was explored
using receiver operated curve analysis. Areas under
the receiver operated curve (AUC) were generated
and compared using the ‘pROC’ version 1.8 R
package (Robin et al. 2011). The accuracy of the LSD,
CDT and IPT for identifying significant cognitive
impairment was compared according to sensitivity,
specificity, positive and negative predictive values
for MoCA score ⩽ 20.
Results
General clinical and demographic characteristics
We assessed a total of 40 elderlymedical patients (mean
age 81.0± 7.71; 21 female). The median MoCA score
was 15.5 (mean 14.9± 7.9; range 1–29), with the major-
ity (n = 35; 88%) scoring below 26 (i.e. the threshold
for significant cognitive impairment). Four of these
patients were CAM positive for delirium while 12 had
documented dementia.
Comparison of performance on the LSD, CDT and IPT
The correlation between the scores on the three tests of
visuospatial ability were as follows: CDT and IPT
(r = 0.42); total LSD score and CDT (r = 0.56), and total
LSD score and IPT (r = 0.71).
For patients who scored 15 on the LSD (the max-
imum score) the range of CDT scores was 5–10. There
were variable scores for the LSD in those subjects who
scored highly (7 or greater) on the CDT. For patients
who scored 15 on the LSD the range of scores on the
IPT was 4–6. These findings indicate correlation that
varies from moderate to strong across the various tests
of visuospatial ability.
Comparison of LSD, CDT and IPT in terms of total
MoCA score
The correlation between Total MoCA and LSD scores
was 0.91 showing a strong positive relationship
between the scores. This was higher than the correlation
between the total MoCA score and the IPT or CDT
(both cases = 0.67).
Correlation between the total LSD score and
individual domains of the MoCA
Table 2 shows the correlation between LSD score
and the seven domains of the MoCA. There was high
correlation with all domains (ranging from 0.54 to
0.86) and especially for the domains of orientation,
attention, delayed recall and visuospatial function.
Identification of significant cognitive impairment on
the MoCA by visuospatial tests
We examined the ability of the tests of visuospatial
function to identify those patients with significant
general cognitive impairment as evidenced by scores of
20 or less on the MoCA. The most accurate cut-off score
in terms of combined sensitivity and specificity values
for the LSD was 2 or more incorrect responses (i.e. pass
if ⩾14) (AUC = 0.99). This cut-off score identified 26 of
the 29 cases with MoCA ⩽21 (90%) and without any
false positives. The equivalent identification for the
CDT (applying the cut-off score of<6) was 17/29 (59%),
while for the IPT (applying the cut-off score of <4)
correct identification was 16/29 (55%). The sensitivity,
specificity, positive and negative predictive values for
performance on the tests of visuospatial tests for
significant cognitive impairment as per a score of ⩽ 20
on the MoCA is shown in Table 3.
Comparison of AUCs (LSD v. CDT and LSD v. IPT)
By using a cut-off point of ⩾14 as equating with a pass
on the LSD, we compared the areas under the curve of
Table 2. Correlation of letter and shape drawing (LSD) test with
Montreal Cognitive Assessment (MoCA) domains








a All correlations statistically significant at 1% level of
significance.
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the CDT and IPT (Hanley & McNeil, 1983). For the first
comparison (LSD v. CDT) the area under the curve was
0.77 (95% CI: 63.03–91.64%) with a power of 0.84 at a
significance level of 0.05. For the second comparison
(LSD v. IPT) the AUC was 0.81 (95% CI: 67.61–94.2%)
with a power of 0.94. Although the accuracy of the IPT
was higher than for the CDT for LSD performance,
a comparison of the two tests indicated that this
was not statistically significant (z = −0.37, p = 0.36).
DISCUSSION
This pilot study indicates that the LSD test can be
readily applied to the testing of cognitive performance
in elderly medical inpatients. The capacity of the LSD to
engage visuospatial abilities was supported by its
agreement with the IPT and CDT, which are commonly
used bedside tests of visuospatial function. In addition,
we found that the LSD correlated very highly with total
MoCA scores and to a substantially greater extent
than either the CDT or IPT. Errors on the LSD were
indicative of significant generalised cognitive impair-
ment such that we were able to identify a cut-off score
with high sensitivity and specificity for patients who
scored in the range for significant cognitive impairment
with the MoCA.
The CDT and IPT are the most commonly used
bedside tests of visuospatial function but have diffi-
culties in terms of the consistency of presentation,
testing procedures and interpretation. The LSD test is
designed to minimise these shortcomings with a
simple presentation using a grid system to optimise
consistency. The scoring of performance is simple and
precise with minimal subjectivity since subjects
must correctly connect the spheres on the grid. This
presentation was developed with the potential to apply
it to touch-sensitive devices where the presentation and
interpretation can be even more consistent. This would
also readily allow for dimensional adjustments (e.g. in
diameter of the circles on the grid or connector
line thickness) according to subject characteristics (e.g.
increased diameter for those with impaired visual
acuity) but such calibration will require further studies
comparing performance on different versions of the test
in subjects with varying visual and/ or fine motor
skills. This ability to adjust testing procedures accord-
ing to subject characteristics can be a significant
advantage of the LSD test over the CDT and IPT.
Rather than conceptualising visuospatial constructive
cognition as a unified construct, many observers cate-
gorise tests according to their content as: assembly versus
graphomotor, copy versus draw-to-command, and
complex versus simple tasks. Some tests (e.g. CDT) tra-
verse these boundaries due to the availability different
versions (Lezak et al. 2004). In a study of visuocon-
structional testing Somerville-Ruffalo (2004) concluded
that the most useful distinction was in terms of com-
plexity level. Complex visuospatial constructive cogni-
tive tasks tend to be more heterogeneous in their
underlying neuropsychological domains and are more
demanding of executive skills. In contrast, simple tests
are more homogenous in function, mostly assessing
visuospatial and perceptual skills. However, they also
concluded that visuospatial function was the primary
determinant of performance on all of the tests they
included, both simple and complex. For our work, we
used a version of the CDT that was intermediate in
complexity (i.e. a pre-drawn circle but without numbers
or hands). Our findings suggest that the LSD is a simpler
tests than either the CDT or IPT as reflected in the
numbers of patients who successfully completed each as
well as correlation in performance across the tests.
There was high correlation between the LSD test and
theMoCA, including each of its individual domains. As
we expected, there was a high correlation with the
visuospatial element of the MoCA but performance on
the LSD also correlated very highly with the orientation
item of the MoCA. These findings suggest that while
emphasising visuospatial abilities, performance on
the LSD also engages other cognitive abilities. One
implication is that the LSD may be useful for testing for
conditions where disorientation is a prominent feature,
such as delirium. Moreover, the concordance between
impaired performance on the LSD test and significant
cognitive impairment on the MoCA suggest that the
LSD test could be useful as a brief test of general
Table 3. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for total Montreal Cognitive Assessment
(MoCA) score ⩽20 according to the clock-drawing test (CDT), interlocking pentagon test (IPT) and letter and shape drawing (LSD) test
Total MoCA score ⩽20
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
CDT score <6 55.2 (35.7–73.6) 90.9 (58.7–99.8) 94.1 (71.3–99.8) 43.5 (23.2–65.5)
IPT score <4 58.6 (38.9–76.5) 90.9 (58.7–99.8) 94.4 (72.7–99.9) 45.5 (24.4–67.8)
LSD score ⩽13 89.7 (72.7–97.8) 100 (71.5–100) 100 (86.8–100) 78.6 (49.2–95.3)
CI, confidence interval.
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cognition that is simple to administer and interpret
while incorporating highly consistent presentation
and administration procedures. These possibilities
warrant further investigation.
Given the variety of neuropsychological processes
that underlie performance on tests of visuospatial
abilities, using a single test may limit the accuracy of
assessment in populations with heterogenous
cognitive abilities (Lezak et al. 2004). The LSD is
designed to traverse a wide range of performance
abilities from simple copying of an ‘X’ in a 3 × 3 grid to
copying a complex shape in a 6× 6 grid. As such, the
various sections of the LSD may engage both simple
and complex functions within a single test and may
allow for more accurate assessment of real world
clinical populations where abilities typically vary
considerably both across patients as well as for
individual patients over time. To this end, our study
identified aspects of the current version of the LSD test
that may warrant amendments. Performance on the
LSD test indicated that the majority of subjects could
readily complete most of the 15 items without error.
While this has positive implications for the ability of the
test to engage clinical populations, the findings also
suggest that the test could be readily abbreviated.
However, many patients who were unable to complete
the other tests without error achieved almost maximum
scores on the LSD test. This suggests that the level of
difficulty of the LSD may need to be increased and that
additional more complex items could improve the
sensitivity of the test in higher functioning subjects.
A major shortcoming of many existing bedside tests of
cognition (including both the CDT and IPT) is that the
level of cognitive function required to register minimal
engagement produces bottoming out effects in clinical
populations where subjects with, for example, delirium
cannot engage even minimally with the test (Bellelli
et al., 2014; European Delirium Association, 2014). It is
hoped that the simplicity of the initial items in the LSD
test can allow for better coverage of performance in
those with severe cognitive impairment. The subjects
included in this study were mostly in the higher range
of performance on the MoCA such that further studies
in patients with more severe cognitive difficulties can
examine this issue in more detail. Overall, this study
suggests that the LSD could be usefully amended
to include fewer items but with some additional
complex items.
This work identified that two or more errors on the
LSD test had high sensitivity and specificity for identify-
ing those subjects with impaired performance on the
MoCA. These preliminary findings should be examined
in a larger study that includes subjects from across amore
complete range of cognitive abilities. In addition, the
accuracy of performance on the LSD for identifying
specific neurocognitive disorders (e.g. delirium) can be
explored in future work where more precise diagnoses
are established. Never the less, the capacity of the LSD
test to allow for rapid and highly consistent cognitive
testing at the bedside supports the possibility that it
can be adapted for a useful role in everyday clinical
practice.
Limitations
This pilot study included a relatively small number
of subjects and did not allow for assessment of the
possible impact of various confounding factors such as
sensory abilities, frailty and educational background on
performance (Hong et al. 2011). In addition, the series of
tests were administered in a specific sequence for all
subjects such that we could not assess the possible
impact of practice effects and/or fatigue with testing. In
an effort to reduce any possible advantage for the LSD
test it was presented last in the series so that it would be
most prone to any negative effects of fatigue. Future
studies can examine this issue by applying testing
sequences that are randomised.
Conclusion
The LSD test is a novel test of cognitive function that
emphasises visuospatial abilities. It allows for simple
and highly consistent testing. Performance on the LSD
test correlates highly with existing gold standard tests
for bedside testing of visuospatial function such as the
CDT and IPT, and also with more generalised cognitive
function measured on the MoCA. The usefulness of the
LSD test may be enhanced by amending the number
and complexity of items. Further larger studies can
examine the reliability and acceptability of the LSD
test in different clinical populations to clarify how it
can be used in the identification of clinically significant
cognitive impairment and specific neurocognitive
disorders in everyday practice.
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